本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

53.36
-1.0700-1.97%
盤後53.360.00000.00%19:30 EDT
成交量:86.70萬
成交額:4,627.65萬
市值:39.10億
市盈率:-31.85
高:54.50
開:54.32
低:52.98
收:54.43
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:0.83
換手率:1.40%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:4.37
市盈率(LYR):-29.16

資料載入中...

2023/11/10

重要事件披露

Form 8-K - Current report
2023/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report
2023/06/29

SEC問詢函

Form CORRESP - Correspondence
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/24

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/03/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/06

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/03/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/01

重要事件披露

Form 8-K - Current report